Some cancers have a reduction in catalase activity, making them more vulnerable than normal cells to hydrogen peroxide from intravenous vitamin C
“"Our results suggest that cancers with low levels of catalase are likely to be the most responsive to high-dose vitamin C therapy, whereas cancers with relatively high levels of catalase may be the least responsive," he explains.”